IP Library Granted Patent US 7,326,238
Granted Patent B1
US 7,326,238 · App. 10/262,149 · Granted Feb 5, 2008

Method and apparatus for treating vulnerable plaque

Assignee: Abbott Cardiovascular Systems Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,326,238
App. No.
10/262,149
Granted
Feb 5, 2008
Kind
B1
Abstract

An apparatus and method to treat vulnerable plaque. In one embodiment, the apparatus has a medical device to treat an occlusive plaque, and is also adapted to release a biologically active agent to treat vulnerable plaque located downstream from the occlusive plaque. In an alternative embodiment, the apparatus has an expandable tube attached to the inner surface of a stent, and a layer of endothelial cells seeded on the inner surface of the expandable tube. The expandable tube shields a vulnerable plaque from a body lumen.

Claims (10)

1. A method comprising:

implanting a stent graft into a body lumen near a vulnerable plaque region, wherein the stent graft has an expandable tube coupled to an inner surface of a stent and a layer of endothelial cells seeded on an inner surface of the expandable tube, and

shielding the vulnerable plaque with the stent graft, wherein the stent graft prevents the vulnerable plaque from rupturing into the body lumen.

2. The method of claim 1 , wherein implanting the stent graft comprises expanding the stent graft near the vulnerable plaque.

3. The method of claim 1 , further comprising coating the stent graft with a vulnerable plaque biologically active agent.

4. The method of claim 3 , further comprising treating the vulnerable plaque with the vulnerable plaque biologically active agent.

5. The method of claim 1 , further comprising strengthening a fibrous cap of the vulnerable plaque.

6. The method of claim 1 , wherein the stent graft comprises a material that is selected from the group consisting of a bioerodable material, a biodegradable polymeric material, a bioerodable material coated with a biologically active agent, and a biodegradable polymeric material coated with a biologically active agent.

7. The method of claim 1 further comprising forming a monolayer of the endothelial cells near the vulnerable plaque region.

8. The method of claim 7 wherein forming comprises the endothelial cells migrating from the inner surface of the expandable tube to a lumen wall near the vulnerable plaque.

Assignments (2)
CHANGE OF NAME Recorded Nov 10, 2011
From: ADVANCED CARDIOVASCULAR SYSTEMS, INC.
To: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Reel/Frame 027212/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2002
From: KILPATRICK, DEBORAH; SIMHAMBHATLA, MURTHY; PRABHU, SANTOSH; QUEE, SHAWN CHIN
To: ADVANCED CARDIOVASCULAR SYSTEMS, INC.
Reel/Frame 013351/0130 →